Aalok Shanghvi
Director/Board Member at SUN PHARMACEUTICAL INDUSTRIES LTD.
Net worth: 51 M $ as of 30/05/2024
Profile
Aalok Dilip Shanghvi is currently the Director, EVP & Head-Business Development at Sun Pharmaceutical Industries Ltd.
He previously worked as a Director at Taro Pharmaceutical Industries Ltd.
and as the Managing Director at Sun Pharmaceutical Industries Ltd.
He completed his undergraduate degree at the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/06/2024 | 2,877,280 ( 0.12% ) | 50 M $ | 30/05/2024 | |
| 30/12/2023 | 350,162 ( 0.11% ) | 864 172 $ | 30/05/2024 |
Aalok Shanghvi active positions
| Companies | Position | Start |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Director/Board Member | 31/05/2023 |
Former positions of Aalok Shanghvi
| Companies | Position | End |
|---|---|---|
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Director/Board Member | 17/07/2013 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Chief Executive Officer | - |
Training of Aalok Shanghvi
| University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Taro Pharmaceutical Industries Ltd.
 Taro Pharmaceutical Industries Ltd. Pharmaceuticals: MajorHealth Technology Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel. | Health Technology |
- Stock Market
- Insiders
- Aalok Shanghvi
